Jaguar Health, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Jaguar Health, Inc. (JAGX) holds an ST Score of 34.5 out of 100 (C-), with its strongest factor being Growth (B) and its weakest Financial Strength (F). Analysts rate JAGX Buy across 5 ratings with a $3.21 average price target (+0.2% vs the current $2.71).
- Strongest
- GrowthB
- Weakest
- Financial StrengthF
All factor grades
- GrowthB
- ForecastB-
- ValuationC
- ProfitabilityC-
- MomentumD
- Financial StrengthF
- Piotroski3/9
Contact
JAGX stock: frequently asked questions
What is JAGX's ST Score?
Jaguar Health, Inc. (JAGX) has an ST Score of 34.5 out of 100, an overall grade of C-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is JAGX a buy, sell, or hold?
Wall Street's consensus rating on JAGX is Buy based on 5 analyst ratings. Our own ST Score grades it C- (34.5/100). This is data, not investment advice — always do your own research.
What is JAGX's valuation grade?
Jaguar Health, Inc. (JAGX) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is JAGX's growth grade?
Jaguar Health, Inc. (JAGX) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is JAGX's profitability grade?
Jaguar Health, Inc. (JAGX) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is JAGX's financial strength grade?
Jaguar Health, Inc. (JAGX) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for JAGX?
The average analyst price target for Jaguar Health, Inc. (JAGX) is $3.21 from 5 analysts, which is +0.2% versus the recent price of $2.71.
What is JAGX's Piotroski score?
Jaguar Health, Inc. (JAGX) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.